Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Acinetobacter

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Acinetobacter

Mark F. Brady et al.
Free Books & Documents

Excerpt

Acinetobacter is a gram-negative, aerobic, non-fermentative, oxidase-negative, and nonmotile organism. Acinetobacter has several species, but A. baumannii has the greatest clinical significance. Acinetobacter can be found in soil and water. Patients are frequently cultured from urine, saliva, respiratory secretions, and open wounds. The organism is also known to colonize intravenous fluids and other irrigation solutions.

In general, Acinetobacter has low virulence but is capable of causing infection in immunocompromised and neutropenic patients. Most of the infections are a result of nosocomial spread and colonization rather than de novo infections. Thus, great care is required when Acinetobacter is isolated - whether it is an actual infection or colonization. Risk factors for Acinetobacter infection include:

  1. Prolonged stay in the intensive care unit

  2. Prolonged antibiotic exposure

  3. Mechanical ventilation

  4. Use of a central venous catheter

  5. Hemodialysis

Most Acinetobacter infections are group outbreaks, and isolated cases are rare. Infections may complicate intravenous (IV) catheter treatment, mechanical ventilation, and even peritoneal dialysis. In most cases, the presence of Acinetobacter in the respiratory secretions of ventilated patients represents colonization.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Mark Brady declares no relevant financial relationships with ineligible companies.

Disclosure: Zohaib Jamal declares no relevant financial relationships with ineligible companies.

Disclosure: Najwa Pervin declares no relevant financial relationships with ineligible companies.

References

    1. Wang T, Costa V, Jenkins SG, Hartman BJ, Westblade LF. Acinetobacter radioresistens infection with bacteremia and pneumonia. IDCases. 2019;15:e00495. - PMC - PubMed
    1. Antunes LC, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014 Aug;71(3):292-301. - PubMed
    1. Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018;11:2277-2299. - PMC - PubMed
    1. Munier AL, Biard L, Legrand M, Rousseau C, Lafaurie M, Donay JL, Flicoteaux R, Mebazaa A, Mimoun M, Molina JM. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit. Int J Infect Dis. 2019 Feb;79:179-184. - PubMed
    1. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008 Apr 15;46(8):1254-63. - PubMed

Publication types

LinkOut - more resources